Schear Investment Advisers’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.27M Buy
5,460
+99
+2% +$36.7K 0.76% 36
2026
Q1
$1.45M Buy
5,361
+92
+2% +$27.4K 0.64% 49
2025
Q4
$1.74M Buy
5,269
+370
+8% +$125K 0.75% 46
2025
Q3
$1.69M Buy
4,899
+231
+5% +$69.9K 0.75% 43
2025
Q2
$1.46M Sell
4,668
-37
-0.8% -$14.1K 0.72% 48
2025
Q1
$2.46M Sell
4,705
-308
-6% -$157K 1.42% 19
2024
Q4
$2.54M Buy
5,013
+117
+2% +$66.5K 1.35% 18
2024
Q3
$2.86M Buy
4,896
+544
+13% +$308K 1.77% 13
2024
Q2
$2.22M Buy
4,352
+86
+2% +$42.2K 1.6% 14
2024
Q1
$2.11M Buy
4,266
+11
+0.3% +$5.59K 1.69% 17
2023
Q4
$2.24M Buy
4,255
+28
+0.7% +$14.9K 2.16% 12
2023
Q3
$2.13M Sell
4,227
-206
-5% -$101K 2.3% 11
2023
Q2
$2.13M Buy
4,433
+9
+0.2% +$4.4K 2.25% 10
2023
Q1
$2.09M Buy
4,424
+82
+2% +$39.6K 2.5% 10
2022
Q4
$2.3M Buy
+4,342
New +$2.3M 2.84% 8

Other funds holding UNH

Schear Investment Advisers's UNH Position: Q2 2026 in Review

Schear Investment Advisers increased its UnitedHealth (UNH) stake by 1.8% in Q2 2026, buying an estimated $36.7K and bringing the position to 5,460 shares worth $2.27M. The position accounts for 0.76% of the portfolio, ranked #36.

Schear Investment Advisers first reported a position in UNH in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.86M in Q3 2024. 3,367 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Schear Investment Advisers held 5,460 shares of UnitedHealth worth $2.27M as of Q2 2026.
  • Schear Investment Advisers bought 99 UnitedHealth shares in Q2 2026, an estimated $36.7K.
  • UnitedHealth made up 0.76% of Schear Investment Advisers's portfolio in Q2 2026, its #36 holding.
  • Schear Investment Advisers first reported a position in UnitedHealth in Q4 2022 and has held it in 15 quarters since.
  • Schear Investment Advisers's UnitedHealth position peaked at $2.86M in Q3 2024.
  • 3,367 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Schear Investment Advisers's 13F filing for Q2 2026, filed 27 Jul 2026.